UNITEDHEALTH GROUP INC (UNH) Fundamental Analysis & Valuation

NYSE:UNH • US91324P1021

Current stock price

364.88 USD
+10.19 (+2.87%)
Last:

This UNH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. UNH Profitability Analysis

1.1 Basic Checks

  • UNH had positive earnings in the past year.
  • In the past year UNH had a positive cash flow from operations.
  • UNH had positive earnings in each of the past 5 years.
  • In the past 5 years UNH always reported a positive cash flow from operatings.
UNH Yearly Net Income VS EBIT VS OCF VS FCFUNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • UNH's Return On Assets of 3.85% is fine compared to the rest of the industry. UNH outperforms 71.00% of its industry peers.
  • UNH has a better Return On Equity (11.59%) than 78.00% of its industry peers.
  • With a Return On Invested Capital value of 5.02%, UNH perfoms like the industry average, outperforming 57.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for UNH is in line with the industry average of 8.40%.
Industry RankSector Rank
ROA 3.85%
ROE 11.59%
ROIC 5.02%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.86%
ROE(5y)20.71%
ROIC(3y)8.98%
ROIC(5y)9.66%
UNH Yearly ROA, ROE, ROICUNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.68%, UNH is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
  • UNH's Profit Margin has declined in the last couple of years.
  • UNH has a Operating Margin (4.19%) which is comparable to the rest of the industry.
  • UNH's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.19%
PM (TTM) 2.68%
GM N/A
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
UNH Yearly Profit, Operating, Gross MarginsUNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

3

2. UNH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UNH is still creating some value.
  • The number of shares outstanding for UNH has been reduced compared to 1 year ago.
  • UNH has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for UNH has been reduced compared to a year ago.
UNH Yearly Shares OutstandingUNH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
UNH Yearly Total Debt VS Total AssetsUNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B

2.2 Solvency

  • UNH has a debt to FCF ratio of 3.98. This is a good value and a sign of high solvency as UNH would need 3.98 years to pay back of all of its debts.
  • UNH has a Debt to FCF ratio of 3.98. This is in the better half of the industry: UNH outperforms 66.00% of its industry peers.
  • A Debt/Equity ratio of 0.69 indicates that UNH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.69, UNH is in line with its industry, outperforming 52.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 3.98
Altman-Z N/A
ROIC/WACC0.58
WACC8.67%
UNH Yearly LT Debt VS Equity VS FCFUNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.3 Liquidity

  • UNH has a Current Ratio of 0.89. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • UNH has a Current ratio of 0.89. This is in the lower half of the industry: UNH underperforms 78.00% of its industry peers.
  • UNH has a Quick Ratio of 0.89. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • UNH's Quick ratio of 0.89 is on the low side compared to the rest of the industry. UNH is outperformed by 73.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
UNH Yearly Current Assets VS Current LiabilitesUNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. UNH Growth Analysis

3.1 Past

  • The earnings per share for UNH have decreased strongly by -41.56% in the last year.
  • Measured over the past years, UNH shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.67% on average per year.
  • The Revenue has grown by 9.67% in the past year. This is quite good.
  • UNH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.72% yearly.
EPS 1Y (TTM)-41.56%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%0.42%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%1.96%

3.2 Future

  • UNH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.88% yearly.
  • UNH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y10.55%
EPS Next 2Y10.88%
EPS Next 3Y13.68%
EPS Next 5Y15.88%
Revenue Next Year-1.61%
Revenue Next 2Y0.98%
Revenue Next 3Y2.65%
Revenue Next 5Y3.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UNH Yearly Revenue VS EstimatesUNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200B 400B 600B
UNH Yearly EPS VS EstimatesUNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

3

4. UNH Valuation Analysis

4.1 Price/Earnings Ratio

  • UNH is valuated rather expensively with a Price/Earnings ratio of 22.33.
  • Based on the Price/Earnings ratio, UNH is valued a bit cheaper than the industry average as 67.00% of the companies are valued more expensively.
  • UNH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.15.
  • Based on the Price/Forward Earnings ratio of 18.20, the valuation of UNH can be described as rather expensive.
  • 66.00% of the companies in the same industry are more expensive than UNH, based on the Price/Forward Earnings ratio.
  • UNH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.12.
Industry RankSector Rank
PE 22.33
Fwd PE 18.2
UNH Price Earnings VS Forward Price EarningsUNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as UNH.
  • 70.00% of the companies in the same industry are more expensive than UNH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.92
EV/EBITDA 15.91
UNH Per share dataUNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as UNH's earnings are expected to grow with 13.68% in the coming years.
PEG (NY)2.12
PEG (5Y)N/A
EPS Next 2Y10.88%
EPS Next 3Y13.68%

7

5. UNH Dividend Analysis

5.1 Amount

  • UNH has a Yearly Dividend Yield of 2.49%. Purely for dividend investing, there may be better candidates out there.
  • UNH's Dividend Yield is rather good when compared to the industry average which is at 0.46. UNH pays more dividend than 96.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, UNH pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.49%

5.2 History

  • The dividend of UNH is nicely growing with an annual growth rate of 12.43%!
  • UNH has paid a dividend for at least 10 years, which is a reliable track record.
  • UNH has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)12.43%
Div Incr Years16
Div Non Decr Years34
UNH Yearly Dividends per shareUNH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

  • UNH pays out 66.50% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of UNH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP66.5%
EPS Next 2Y10.88%
EPS Next 3Y13.68%
UNH Yearly Income VS Free CF VS DividendUNH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B
UNH Dividend Payout.UNH Dividend Payout, showing the Payout Ratio.UNH Dividend Payout.PayoutRetained Earnings

UNH Fundamentals: All Metrics, Ratios and Statistics

UNITEDHEALTH GROUP INC

NYSE:UNH (4/28/2026, 11:11:09 AM)

364.88

+10.19 (+2.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-21
Earnings (Next)07-27
Inst Owners84.08%
Inst Owner Change-0.41%
Ins Owners0.16%
Ins Owner Change-0.26%
Market Cap331.19B
Revenue(TTM)449.71B
Net Income(TTM)12.04B
Analysts75.88
Price Target395.93 (8.51%)
Short Float %1.69%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 2.49%
Yearly Dividend8.69
Dividend Growth(5Y)12.43%
DP66.5%
Div Incr Years16
Div Non Decr Years34
Ex-Date03-09
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.15%
Min EPS beat(2)-0.58%
Max EPS beat(2)8.88%
EPS beat(4)2
Avg EPS beat(4)0.47%
Min EPS beat(4)-9.92%
Max EPS beat(4)8.88%
EPS beat(8)5
Avg EPS beat(8)0.28%
EPS beat(12)9
Avg EPS beat(12)1.31%
EPS beat(16)13
Avg EPS beat(16)1.93%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)0.95%
Revenue beat(8)2
Avg Revenue beat(8)-0.91%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)6
Avg Revenue beat(16)-0.31%
PT rev (1m)-0.92%
PT rev (3m)-8.9%
EPS NQ rev (1m)2.4%
EPS NQ rev (3m)5.92%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-3.49%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-3.05%
Valuation
Industry RankSector Rank
PE 22.33
Fwd PE 18.2
P/S 0.74
P/FCF 16.92
P/OCF 14.36
P/B 3.19
P/tB 3.19
EV/EBITDA 15.91
EPS(TTM)16.34
EY4.48%
EPS(NY)20.05
Fwd EY5.5%
FCF(TTM)21.56
FCFY5.91%
OCF(TTM)25.4
OCFY6.96%
SpS495.45
BVpS114.46
TBVpS114.46
PEG (NY)2.12
PEG (5Y)N/A
Graham Number205.139 (-43.78%)
Profitability
Industry RankSector Rank
ROA 3.85%
ROE 11.59%
ROCE 6.15%
ROIC 5.02%
ROICexc 5.59%
ROICexgc 19.97%
OM 4.19%
PM (TTM) 2.68%
GM N/A
FCFM 4.35%
ROA(3y)5.63%
ROA(5y)6.65%
ROE(3y)17.86%
ROE(5y)20.71%
ROIC(3y)8.98%
ROIC(5y)9.66%
ROICexc(3y)9.97%
ROICexc(5y)10.8%
ROICexgc(3y)28.02%
ROICexgc(5y)30.44%
ROCE(3y)11.07%
ROCE(5y)11.9%
ROICexgc growth 3Y-21.25%
ROICexgc growth 5Y-12.15%
ROICexc growth 3Y-19.22%
ROICexc growth 5Y-11.85%
OM growth 3Y-21.54%
OM growth 5Y-13.43%
PM growth 3Y-24.29%
PM growth 5Y-14.77%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 3.98
Debt/EBITDA 3.08
Cap/Depr 80.55%
Cap/Sales 0.78%
Interest Coverage 250
Cash Conversion 99.55%
Profit Quality 162.5%
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z N/A
F-Score6
WACC8.67%
ROIC/WACC0.58
Cap/Depr(3y)84.55%
Cap/Depr(5y)83.03%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.86%
Profit Quality(3y)129.12%
Profit Quality(5y)123.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-41.56%
EPS 3Y-9.75%
EPS 5Y-0.67%
EPS Q2Q%0.42%
EPS Next Y10.55%
EPS Next 2Y10.88%
EPS Next 3Y13.68%
EPS Next 5Y15.88%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y11.35%
Revenue growth 5Y11.72%
Sales Q2Q%1.96%
Revenue Next Year-1.61%
Revenue Next 2Y0.98%
Revenue Next 3Y2.65%
Revenue Next 5Y3.86%
EBIT growth 1Y-43.73%
EBIT growth 3Y-12.63%
EBIT growth 5Y-3.28%
EBIT Next Year29.57%
EBIT Next 3Y17.04%
EBIT Next 5Y15.62%
FCF growth 1Y86.12%
FCF growth 3Y-12.42%
FCF growth 5Y-4.82%
OCF growth 1Y66.07%
OCF growth 3Y-9.63%
OCF growth 5Y-2.7%

UNITEDHEALTH GROUP INC / UNH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UNITEDHEALTH GROUP INC?

ChartMill assigns a fundamental rating of 4 / 10 to UNH.


Can you provide the valuation status for UNITEDHEALTH GROUP INC?

ChartMill assigns a valuation rating of 4 / 10 to UNITEDHEALTH GROUP INC (UNH). This can be considered as Fairly Valued.


What is the profitability of UNH stock?

UNITEDHEALTH GROUP INC (UNH) has a profitability rating of 4 / 10.


How financially healthy is UNITEDHEALTH GROUP INC?

The financial health rating of UNITEDHEALTH GROUP INC (UNH) is 3 / 10.


Can you provide the dividend sustainability for UNH stock?

The dividend rating of UNITEDHEALTH GROUP INC (UNH) is 7 / 10 and the dividend payout ratio is 66.5%.